Compositions and methods of manufacturing trivalent filovirus vaccines
ZA202403525BActive Publication Date: 2026-08-26SOLIGENIX INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ZA202403525
- Authority / Receiving Office
- ZA · ZA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-05-20
- Filing Date
- 2024-05-08
- Publication Date
- 2026-08-26
- Estimated Expiration
- 2044-05-08
Abstract
Disclosed is a stable immunogenic composition capable of eliciting a robust and durable immune response, comprising at least one antigen consisting of a filovirus glycoprotein and at least one nano-emulsion adjuvant which are co-lyophilized and can be reconstituted immediately prior to use. Also disclosed is a vaccine composition comprising at least two antigens, wherein each antigen is specific to a different genus of filovirus and which also comprises at least one nano-emulsion adjuvant.
Need to check novelty before this filing date? Find Prior Art